+919405117673

Revolade Tablets (Eltrombopag) Available in Global Markets – Trusted Supply by Cordium Pharmaceuticals Pvt. Ltd.

Cordium Pharmaceuticals Pvt. Ltd. provides reliable pharmaceutical supply solutions for Revolade Tablets (Eltrombopag) for international markets including Morocco, Kenya, Singapore, Australia, Germany, Canada, and Saudi Arabia.

Revolade Tablets contain Eltrombopag, a thrombopoietin receptor agonist (TPO-RA) used under medical supervision to support platelet production in patients with approved hematological disorders.

With a focus on quality, compliance, and global pharmaceutical distribution, Cordium Pharmaceuticals Pvt. Ltd. supports hospitals, pharmacies, distributors, and healthcare organizations worldwide.


What Are Revolade Tablets (Eltrombopag)?

Revolade is a prescription medicine containing Eltrombopag Olamine, which works by stimulating thrombopoietin receptors and helping the body produce more platelets.

Eltrombopag is commonly used for:

  • Chronic Immune Thrombocytopenia (ITP)
  • Severe Aplastic Anemia (SAA)
  • Other approved platelet-related disorders according to country-specific guidelines

Treatment should always be started and monitored by a qualified healthcare professional.


Revolade Tablets Available Strengths

Cordium Pharmaceuticals supports supply requirements for:

  • Revolade 25 mg Tablets
  • Revolade 50 mg Tablets
  • Revolade 75 mg Tablets

Strength availability may vary depending on market regulations and requirements.


Global Availability of Revolade Tablets

Revolade Tablets in Morocco

Cordium Pharmaceuticals Pvt. Ltd. supports pharmaceutical supply solutions for healthcare providers, pharmacies, and distributors in Morocco with professional export assistance.

Revolade Tablets in Kenya

Reliable pharmaceutical sourcing solutions for Kenya with quality-focused supply and export support.

Revolade Tablets in Singapore

Supporting healthcare organizations and pharmaceutical partners in Singapore with dependable international supply services.

Revolade Tablets in Australia

Providing pharmaceutical export solutions for approved healthcare channels in Australia.

Revolade Tablets in Germany

Helping healthcare distributors and organizations access quality pharmaceutical products from India.

Revolade Tablets in Canada

Supporting Canadian pharmaceutical buyers with documentation assistance and international supply solutions.

Revolade Tablets in Saudi Arabia

Providing reliable pharmaceutical supply support for hospitals, pharmacies, and healthcare distributors in Saudi Arabia.


Why Choose Cordium Pharmaceuticals Pvt. Ltd.?

Cordium Pharmaceuticals Pvt. Ltd. is a trusted Indian pharmaceutical exporter committed to delivering quality medicines and healthcare solutions globally.

Key Benefits of Choosing Cordium Pharma

✅ Experienced pharmaceutical export company from India
✅ Quality-focused manufacturing and sourcing process
✅ International shipping and logistics support
✅ Regulatory documentation assistance
✅ Wide portfolio of specialty medicines
✅ Reliable supply chain management
✅ Competitive pricing solutions for global buyers
✅ Dedicated customer support for distributors and healthcare partners


Benefits of Revolade Tablets

  • Helps increase platelet production in eligible patients
  • Oral tablet dosage form
  • Used for specific hematological conditions
  • Convenient administration compared with injectable therapies
  • Available in multiple strengths

Important Information About Revolade Tablets

  • Revolade is a prescription-only medicine.
  • Use only under the guidance of a healthcare professional.
  • Regular monitoring may be required during treatment.
  • Dosage depends on patient condition, platelet response, and physician recommendation.



Frequently Asked Questions (FAQs)

1. What is Revolade Tablet used for?

Revolade Tablet contains Eltrombopag and is prescribed for approved conditions such as chronic immune thrombocytopenia (ITP) and severe aplastic anemia (SAA) under medical supervision.


2. What is the active ingredient in Revolade?

The active ingredient is Eltrombopag Olamine.


3. Is Revolade available in Morocco, Kenya, Singapore, Australia, Germany, Canada, and Saudi Arabia?

Availability depends on local regulatory approvals, import requirements, and authorized pharmaceutical supply channels.


4. What strengths of Revolade Tablets are available?

Common strengths include:

  • 25 mg
  • 50 mg
  • 75 mg

5. Can Revolade Tablets be purchased without a prescription?

No. Revolade is a prescription medicine and should only be used after consultation with a healthcare professional.


6. Does Cordium Pharmaceuticals supply medicines internationally?

Yes, Cordium Pharmaceuticals Pvt. Ltd. provides international pharmaceutical supply solutions for approved global markets.


7. How can I request Revolade Tablets availability and pricing?

International buyers can contact Cordium Pharmaceuticals Pvt. Ltd. with their required quantity, destination country, and documentation requirements to receive product information and quotation.


8. Why choose Cordium Pharmaceuticals for Revolade supply?

Cordium Pharmaceuticals offers:

  • Quality pharmaceutical solutions
  • Global export support
  • Reliable logistics assistance
  • Professional customer service
  • Competitive business solutions

9. Who can purchase Revolade Tablets from Cordium Pharma?

Hospitals, pharmacies, pharmaceutical distributors, healthcare organizations, and authorized importers can contact Cordium Pharmaceuticals for supply inquiries.


10. Why is Eltrombopag used in platelet disorders?

Eltrombopag works by activating thrombopoietin receptors, which may help stimulate platelet production in eligible patients.


Conclusion

For Revolade Tablets (Eltrombopag) availability in Morocco, Kenya, Singapore, Australia, Germany, Canada, and Saudi Arabia, Cordium Pharmaceuticals Pvt. Ltd. provides trusted pharmaceutical export solutions with quality-focused service, reliable supply, and global distribution support.

Partner with Cordium Pharmaceuticals Pvt. Ltd. for dependable pharmaceutical sourcing from In

Jul 31st, 2026 3:29 PM